Analysis of how the Lower Costs, More Transparency Act, signed in late 2023, aims to reduce drug costs up to…
What CMS drug price negotiations mean for patient costs and access
CMS expands drug price negotiations to include physician-administered drugs under the Inflation Reduction Act, targeting $25 billion in savings over…
What U.S. telemedicine policy alignment means for patient outcomes
Analytical exploration of U.S. telemedicine policy efforts, focusing on legislative extensions, AI integration in stroke care, and international comparisons to…
What ATA’s 2024 AI framework means for clinical accountability
The American Telemedicine Association’s updated AI policy principles emphasize risk-based accountability and performance monitoring, aiming to guide safe AI integration…
What Mass General Brigham’s hospital-at-home model means for CMS reimbursement and equity in 2024
Analysis of hospital-at-home models’ impact on U.S. healthcare policy, focusing on CMS waiver extensions, Mass General Brigham’s data showing 30%…
What DEA and HHS telemedicine extension means for patient access to Schedule II-V medications
The DEA and HHS extended telemedicine flexibilities through 2026, addressing the ‘telemedicine cliff’ to maintain remote prescribing of controlled substances.…
What the HHS gender-affirming care lawsuit means for federal healthcare equity
Analysis of the lawsuit by 19 states and D.C. against HHS over gender-affirming care policies, exploring regulatory overreach claims, clinical…
Singapore’s NPM programme unveils phase 2 targeting hereditary cancers and kidney diseases
Singapore’s National Precision Medicine programme expands into phase 2, focusing on hereditary cancers and kidney diseases with digital health integration…
What CMS’s 5-star bonus reinstatement means for Medicare Advantage funding and chronic disease outcomes
CMS’s proposed changes to Medicare Advantage star ratings, reinstating a bonus system and eliminating certain measures, could impact $13 billion…
What FDA and WHO vaccine regulatory updates mean for public health outcomes
This article examines recent FDA and WHO proposals to update vaccine ingredients and schedules, based on clinical evidence from studies…
What H.R.5371 telehealth extension means for Medicare cost efficiencies and rural care
The extension of Medicare telehealth flexibilities to January 2026 under H.R.5371 supports patient access and cost savings, but temporary measures…
AI and Policy Synergies Transform Obesity Drug Market Dynamics
Recent government policies and AI initiatives are reshaping the obesity drug market, with CMS expanding AI prior authorization pilots and…